Precigen, Inc. (PGEN)
7.54
-0.01
(-0.13%)
USD |
NASDAQ |
Oct 07, 16:00
7.55
+0.01
(+0.13%)
After-Hours: 20:00
Precigen Market Cap : 2.699B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 2.699B |
| October 06, 2026 | 2.703B |
| October 05, 2026 | 2.771B |
| October 02, 2026 | 3.057B |
| October 01, 2026 | 2.939B |
| September 30, 2026 | 3.065B |
| September 29, 2026 | 2.882B |
| September 28, 2026 | 2.796B |
| September 25, 2026 | 2.775B |
| September 24, 2026 | 2.757B |
| September 23, 2026 | 2.664B |
| September 22, 2026 | 2.825B |
| September 21, 2026 | 2.757B |
| September 18, 2026 | 2.785B |
| September 17, 2026 | 2.818B |
| September 16, 2026 | 2.662B |
| September 15, 2026 | 2.506B |
| September 14, 2026 | 2.452B |
| September 11, 2026 | 2.452B |
| September 10, 2026 | 2.391B |
| September 09, 2026 | 2.434B |
| September 08, 2026 | 2.460B |
| September 04, 2026 | 2.542B |
| September 03, 2026 | 2.556B |
| September 02, 2026 | 2.510B |
| Date | Value |
|---|---|
| September 01, 2026 | 2.456B |
| August 31, 2026 | 2.481B |
| August 28, 2026 | 2.488B |
| August 27, 2026 | 2.574B |
| August 26, 2026 | 2.656B |
| August 25, 2026 | 2.606B |
| August 24, 2026 | 2.567B |
| August 21, 2026 | 2.578B |
| August 20, 2026 | 2.664B |
| August 19, 2026 | 2.563B |
| August 18, 2026 | 2.417B |
| August 17, 2026 | 2.345B |
| August 14, 2026 | 2.184B |
| August 13, 2026 | 2.323B |
| August 12, 2026 | 2.452B |
| August 11, 2026 | 2.456B |
| August 10, 2026 | 2.506B |
| August 07, 2026 | 2.588B |
| August 06, 2026 | 2.474B |
| August 05, 2026 | 2.467B |
| August 04, 2026 | 2.338B |
| August 03, 2026 | 2.366B |
| July 31, 2026 | 2.232B |
| July 30, 2026 | 2.114B |
| July 29, 2026 | 1.940B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Repligen Corp. | 9.436B |
| AC Immune SA | 234.13M |
| Amgen, Inc. | 223.31B |
| Geron Corp. | 770.96M |
| Neurocrine Biosciences, Inc. | 14.58B |
Market Cap Related Metrics
| PS Ratio | 31.43 |
| PEG Ratio | -0.0438 |
| Price to Book Value | 61.95 |
| Price | 7.54 |
| Earnings Yield | -14.58% |
| PEGY Ratio | -0.0438 |